District-Wide Use of Epinephrine Injectors

The board of education has authorized the superintendent to obtain a prescription for Epinephrine injectors in the name of the school.  This prescription will be of a quantity sufficient to provide for two (2) injectors at each site.  

The superintendent will designate personnel at each site to:

• be responsible for obtaining and maintaining an adequate supply of injectors from the central office;  
• ensure appropriate training on the administration of the injectors for designated staff members; 
• distribute and maintain annual parent/guardian consent forms.

No employee, except a school nurse, will be required to agree to be trained in the use of Epinephrine injectors or to administer Epinephrine injections.  

District employees are still required to call 911 in the event of an emergency, including any time an Epinephrine injector is used.

Annual written notice will be provided to all parents/guardians that trained employees are authorized to administer Epinephrine injections to any student who appears to be having an anaphylactic reaction if the parent /guardian has given written consent and waived liability related to the good faith use of the injection.  No Epinephrine injection shall be given if the proper written consent is not on file with the district.

District-Wide Use of Stock Inhaler

Annual written notice will be provided to all parents/guardians that trained employees are authorized to administer Epinephrine injections to any student who in good faith appears to be having respiratory distress. Title 70 O.S. §1-116.3

• “Respiratory distress” means the perceived or actual presence of coughing, wheezing or shortness of breath.
• “Inhaler” means a device that delivers a bronchodilator to alleviate symptoms of respiratory distress that is manufactured in the form of a metered-dose inhaler or dry-powder inhaler and that my include a spacer or holding chamber that attaches to the inhaler to improve the delivery of the bronchodilator.

District-Wide Use of Glucagon

The board of education has authorized the superintendent to obtain a prescription for Glucagon in the name of the school district.

The school district will:

• inform, in writing, the parent or legal guardian of each student with a diabetes medical management plan that a school nurse, school employee trained by a health care professional or a school employee who has volunteered and successfully completed training to be a diabetes care assistant may administer, with parent or legal guardian written consent but without a health care provider order, Glucagon to a student with diabetes whom the school nurse, trained employee, or a school employee who has volunteered and successfully completed training to be a diabetes care assistant in good faith believes is having a hypoglycemic emergency or if the student’s prescribed Glucagon is not available on site or has expired;
• designate the employee responsible for obtaining Glucagon for each school site from a licensed physician with prescriptive authority; and
• maintain Glucagon at each school site in accordance with the manufacturer’s instructions.

School employees are still required to call a student’s parent or guardian and 911 in the event of an emergency, including any time an employee believes a student is experiencing a hypoglycemic emergency.

A waiver of liability executed by a parent or legal guardian must be on file with the school district prior to administration of Glucagon.  Written consent and waiver of liability shall be effective for the school year in which it is granted and shall be renewed each subsequent school year.

Administration of an Emergency Opioid Antagonist (e.g., Naloxone) by District Personnel

District medical personnel (certified school nurse or any other nurse employed by or under contract with the district) or any other person designated by the Superintendent may administer, regardless of whether there is a prescription or standing order in place, an emergency opioid antagonist for a suspected opioid overdose by a student or other individual exhibiting signs of an opioid overdose. 

The Superintendent may authorize one or more district employees to receive training offered by the Department of Mental Health and Substance Abuse Services, a law enforcement agency or any other entity in recognizing the signs of an opioid overdose and administering an emergency opioid antagonist. The Superintendent may designate persons to receive this training who have been required to receive annual training in cardiopulmonary resuscitation and the Heimlich maneuver (70 Okla. Stat. §1210.199).   Furthermore, if a person or persons designated and trained to administer an emergency opioid antagonist are absent, the Superintendent or designee may authorize any person, regardless of whether there is a prescription or standing order in place, to administer an emergency opioid antagonist to a student or other individual exhibiting signs of an overdose.  

Any person administering an emergency opioid antagonist to a student or other individual at a school site or school-sponsored event, in a manner consistent with addressing opioid overdose, shall be covered by Oklahoma’s Good Samaritan Act.  In the event of a suspected overdose, the district and its employees or designees shall be immune from civil liability in relation to the administration of an emergency opioid antagonist.

Any first responder who administers or provides an emergency opioid antagonist in good faith and in a manner consistent with addressing opioid overdose is not liable for any civil damages as a result of any acts or omissions by such first responder except for committing gross negligence or willful wanton wrongs in administering or providing such emergency opioid antagonist.   Pursuant to OKLA. STAT. tit. 63, § 1-2506.1, for purposes of this section a “first responder” shall include medical personnel at schools including any public or charter schools, technology center schools and institutions of higher education.  “Medical personnel at schools” means a certified school nurse or any other nurse employed by or under contract with a district, any licensed practitioner of the healing arts, or any person designated by the school administration to administer an emergency opioid antagonist.  

As used in this section, “emergency opioid antagonist” means a drug including, but not limited to, naloxone that blocks the effects of opioids and that is approved by the United States Food and Drug Administration for the treatment of an opioid overdose.

The Oklahoma State Health Department considers head lice contagious and students will be sent home and will not be readmitted until the provisions of board Policy FFA-E are followed.  Specifically, the student must have a clearance note from the Health Department or doctor and must be nit free. 

If a student becomes ill at school, he/she should tell their teacher.  The student’s temperature will be taken in the office.  If the child has a fever, a parent/guardian will be contacted.  If there is no fever, the student will rest in the office and if there is no improvement a parent/guardian will be contacted.

Injury at School

If a student is injured at school, we attend to minor incidents.  If it is apparent that medical attention is needed, we will attempt to contact a parent/guardian.  If a parent/guardian cannot be located in an emergency situation, we will use the emergency medical form to seek immediate medical attention. 

Type 1 Diabetes Parent Flyer

Diabetic Students

Diabetic students should have a Diabetic Medical Emergency Plan on file with the school office.  Please contact your child’s school office to request the appropriate paper work.

eningococcal disease is a rare but sometimes fatal disease caused by a bacterium.  The disease causes either meningitis, severe swelling of the brain and spinal cord, or meningococcemia, a serious infection of the blood.  Teenagers and young adults, aged 15 to 22 years, are at increased risk because of behaviors that spread the disease.  On average two to three people in this age group get meningococcal disease every year in Oklahoma.  More than half of these could be prevented by vaccine.  For more information contact your healthcare provider or local county health department or visit these websites:

National Meningitis Association

Immunization Action Coalition

Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health

Immunization Action Coalition

Institute for Vaccine Safety Johns Hopkins Bloomberg School of Public Health

In accordance with state law, students are expected to be up-to-date on all required vaccinations or have a signed exemption form on file.
​​​​​​​More information can be found at:Oklahoma/gov/health/services

Immunization Action Coalition